1. |
Guo L, Bai Y, Ji SZ, et al. MicroRNA-98 suppresses cell growth and invasion of retinoblastoma via targeting the IGF1R/k-Ras/Raf/MEK/ERK signaling pathway[J]. Int J Oncol, 2019, 54(3): 807-820. DOI: 10.3892/ijo.2019.4689.
|
2. |
Kooi IE, Mol BM, Moll AC, et al. Loss of photoreceptorness and gain of genomic alterations in retinoblastoma reveal tumor progression[J]. EBioMedicine, 2015, 2(7): 660-670. DOI: 10.1016/j.ebiom.2015.06.022.
|
3. |
McEvoy J, Flores-Otero J, Zhang JK, et al. Coexpression of normally incompatible developmental pathways in retinoblastoma genesis[J]. Cancer Cell, 2011, 20(2): 260-275. DOI: 10.1016/j.ccr.2011.07.005.
|
4. |
Kapatai G, Brundler MA, Jenkinson H, et al. Gene expression profiling identifies different sub-types of retinoblastoma[J]. Br J Cancer, 2013, 109(2): 512-525. DOI: 10.1038/bjc.2013.283.
|
5. |
Mohammad G, AlSharif HM, Siddiquei MM, et al. Rho-associated protein kinase-1 mediates the regulation of inflammatory markers in diabetic retina and in retinal müller cells[J]. Ann Clin Lab Sci, 2018, 48(2): 137-145.
|
6. |
Yang WJ, Wang YY, Yu Z, et al. SOX11 regulates the pro-apoptosis signal pathway and predicts a favorable prognosis of mantle cell lymphoma[J]. Int J Hematol, 2017, 106(2): 212-220. DOI: 10.1007/s12185-017-2236-y.
|
7. |
Teng Y, Fan YC, Mu NN, et al. Serum SOX11 promoter methylation is a novel biomarker for the diagnosis of Hepatitis B virus-related hepatocellular carcinoma[J]. Neoplasma, 2016, 63(3): 419-426. DOI: 10.4149/311_151029N552.
|
8. |
Liu Z, Zhong Y, Chen YJ, et al. SOX11 regulates apoptosis and cell cycle in hepatocellular carcinoma via Wnt/β-catenin signaling pathway[J]. Biotechnol Appl Biochem, 2019, 66(2): 240-246. DOI: 10.1002/bab.1718.
|
9. |
Zhang S, Li S, Gao JL. Promoter methylation status of the tumor suppressor gene SOX11 is associated with cell growth and invasion in nasopharyngeal carcinoma[J]. Cancer Cell Int, 2013, 13(1): 109. DOI: 10.1186/1475-2867-13-109.
|
10. |
Xu XY, Chang XJ, Li ZH, et al. Aberrant SOX11 promoter methylation is associated with poor prognosis in gastric cancer[J]. Cell Oncol (Dordr), 2015, 38(3): 183-194. DOI: 10.1007/s13402-015-0219-7.
|
11. |
Goyal B, Duncavage EJ, Martinez D, et al. Next-generation sequencing of salivary high-grade neuroendocrine carcinomas identifies alterations in RB1 and the mTOR pathway[J]. Exp Mol Pathol, 2014, 97(3): 572-578. DOI: 10.1016/j.yexmp.2014.10.011.
|